Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fang Zheng and Zhiguo Zhou.
Fang Zheng
Connection Strength
1.356
Zhiguo Zhou
  1. Reply to "Novaferon, treatment in COVID-19 patients". Int J Infect Dis. 2021 02; 103:336-337.
    View in: PubMed
    Score: 0.229
  2. Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19. Signal Transduct Target Ther. 2020 11 24; 5(1):276.
    View in: PubMed
    Score: 0.229
  3. First patient management of COVID-19 in Changsha, China: a case report. BMC Infect Dis. 2020 Nov 11; 20(1):824.
    View in: PubMed
    Score: 0.228
  4. Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China. Medicine (Baltimore). 2020 Aug 21; 99(34):e21824.
    View in: PubMed
    Score: 0.225
  5. SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial. Int J Infect Dis. 2020 Oct; 99:84-91.
    View in: PubMed
    Score: 0.224
  6. Clinical characteristics of older and younger patients infected with SARS-CoV-2. Aging (Albany NY). 2020 06 22; 12(12):11296-11305.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.